Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
See Latest ArticlesElevated Lymphotoxin Causes Liver Cancer
Ivanhoe, 10/09/09
A recent study proposes a new therapeutic strategy for treating liver diseases by mapping the pathway that leads from infection with Hepatitis B and C virus to chronic hepatitis and liver cancer. The research describes a signaling pathway that can be beneficial during liver regeneration, but which also can lead to chronic hepatitis and severe liver damage when chronically activated.
Today in Popular Press...keeping you current
Receive free subspecialty "5-minute updates" via email
Easily led ash-tray: Adolescent smokers prone to drug abuse
EurekAlert, 12/14/09
Pathological gambling may be successfully treated with medications for substance addiction
EurekAlert, 12/11/09
How calorie-restricted diets fight obesity and extend life span
EurekAlert, 12/10/09
Sponsor
Article Search
Sponsor
Sponsor